BioNTech (BNTX) announced that the Supervisory Board has appointed Annemarie Hanekamp to the Management Board as Chief Commercial Officer effective July 1. She will join BioNTech from Novartis (NVS) and succeed Sean Marett in this role.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BNTX:
- Novavax (NASDAQ:NVAX) Remains Highly Speculative, Post-Pandemic
- Autolus Therapeutics price target raised to $10 from $9 at Truist
- Options Volatility and Implied Earnings Moves This Week, March 18 – March 21, 2024
- BNTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- BioNTech to present clinical data updates for oncology candidates